Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Cariprazine-D8 Solution, 100 μg/mL (0.1% HCl in Acetonitrile (v/v)), Sold by MilliporeSigma™ Supelco™
Certified reference material
Manufacturer: MilliporeSigma Supelco C1791ML
Description
Cariprazine, sold as Vraylar in the US and Reagila in Europe, is an atypical antipsychotic used in the treatment of schizophrenia and bipolar mania. This stable-labeled internal standard is suitable for quantitation of Cariprazine levels in urine, serum, or plasma by LC/MS or GC/MS for clinical toxicology, forensic analysis, and urine drug testing applications.Specifications
75-05-8, 1308278-50-3 | |
100 μg/mL (0.1% HCl in acetonitrile (v/v)) | |
Ampule | |
1 mL |
C21H24D8Cl2N4O | |
435.46 | |
-20°C | |
2°C (35.6°F) - closed cup |
Safety and Handling
H332-H319
H312
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
CERILLIANT is a registered trademark of Cerilliant Corporation